Open AccessResponse to Cabozantinib Following Acquired Entrectinib Resistance in a Patient WithETV6-NTRK3Fusion-Positive Carcinoma Harboring theNTRK3G623RSolvent-Front Mutation
Author(s) -
Dorothea Hanf,
Christoph Heining,
Karin Laaber,
Heiner Nebelung,
Sebastian Uhrig,
Barbara Hutter,
Arne Jahn,
Daniela Richter,
Daniela E. Aust,
Friederike Herbst,
Stefan Fröhling,
Hanno Glimm,
Gunnar Folprecht
Publication year - 2021
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.20.00278
Subject(s) - cabozantinib , cancer research , medicine , mutation , oncology , biology , genetics , gene , vegf receptors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom